Appointment booking for Dr. Monty Metcalfe, MD is currently not available.Dr. Monty Metcalfe, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Monty Metcalfe, MD (he/him) is a Oncologist in Lexington, KY with over 18 years of experience. What is your opinion of Dr. Monty Metcalfe, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Monty Metcalfe, MD has received over $1,660 which includes payments from the following companies:
$390.92 from Janssen Biotech, Inc.
$225.32 from Pfizer Inc.
$155.93 from Genentech USA, Inc.
$153.75 from E.R. Squibb & Sons, L.L.C.
$147.83 from ProStrakan, Inc.
$104.88 from Gilead Sciences Inc
$97.00 from Eisai Inc.
$67.12 from Novartis Pharmaceuticals Corporation
$51.07 from Teva Pharmaceuticals USA, Inc.
$44.77 from AstraZeneca Pharmaceuticals LP
$30.52 from Amgen Inc.
$25.89 from TESARO, Inc.
$23.95 from Bayer HealthCare Pharmaceuticals Inc.
$21.73 from GlaxoSmithKline, LLC.
$21.18 from Medtronic USA, Inc.
$20.65 from GENZYME CORPORATION
$15.19 from AbbVie, Inc.
$14.44 from Mylan Institutional Inc.
$13.98 from Kite Pharma, Inc.
$13.41 from LILLY USA, LLC
Payments received by Dr. Monty Metcalfe, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!